Log In|Sign Up
EN
Exon 2 was replaced with a modified one in which nucleotide substitutions (TAT to GCT) result in the amino acid substitution of alanine for tyrosine at position 297 (Y297A). This mutation reduces VEGF164 binding. Cre-mediated recombination removed the floxed neomycin resistance cassette inserted downstream of the modified exon 2. Immunoblotting confirmed severely reduced protein expression in the brain, heart and kidney. (J:208348)
Basic Information
Allele
Strain of Origin
Allele Type
Mutation
Inheritance
Related Gene
Related Disease
Reference
Phenotypes
Legend：
hm: homozygous
ht: heterozygous
cn: conditional genotype
cx: complex: > 1 genome feature
tg: involves transgenes
ot: other: hemizygous, indeterminate,...
(F): Female
(M): Male
phenotype observed
N: normal phenotype
(#): related diseases count
Phenotypes：
Show/Hide columns
| Phenotypes |
|---|
References Literature
Title
PMID
Journal
Year
IF
